Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDL
- 1 April 2000
- journal article
- Published by Elsevier in Metabolism
- Vol. 49 (4) , 479-485
- https://doi.org/10.1016/s0026-0495(00)80012-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemiaAtherosclerosis, 1996
- Lipids and oxidised lipids in human atherosclerotic lesions at different stages of developmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interactionAtherosclerosis, 1995
- Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patientsAtherosclerosis, 1995
- Oxidized low‐density lipoprotein is cytotoxic to human monocyte‐macrophages: protection with lipophilic antioxidantsFEBS Letters, 1995
- Conformational changes in oxidized LDL recognized by mouse peritoneal macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.Journal of Clinical Investigation, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The effect of EDTA on the oxidation of low density lipoproteinAtherosclerosis, 1992
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987